Why the study?
The precise role of different subsets of heterogenous cardiac macrophages in ischemia/reperfusion injury remains incomplete.
Resident macrophages orchestrate inflammatory responses that improve cardiac remodeling, while recruited macrophages determine infarct size after ischemia/reperfusion injury.
Answers are grounded in this paper and cite their sources.
Resident macrophage preservation may aid post-MI remodeling in mice; hypothesis-generating for macrophage-targeted therapies in human ischemia/reperfusion injury.
Cardiac macrophages are heterogenous in phenotype and functions, which has been associated with differences in their ontogeny. Despite extensive research, our understanding of the precise role of different subsets of macrophages in ischemia/reperfusion injury remains incomplete. We here investigated macrophage lineages and ablated tissue macrophages in homeostasis and after I/R injury in a CSF1R-dependent manner. Genomic deletion of a fms-intronic regulatory element (FIRE) in the Csf1r locus resulted in specific absence of resident homeostatic and antigen-presenting macrophages, without affecting the recruitment of monocyte-derived macrophages to the infarcted heart. Specific absence of homeostatic, monocyte-independent macrophages altered the immune cell crosstalk in response to injury and induced proinflammatory neutrophil polarization, resulting in impaired cardiac remodelling without influencing infarct size. In contrast, continuous CSF1R inhibition led to depletion of both resident and recruited macrophage populations. This augmented adverse remodelling after I/R and led to an increased infarct size and deterioration of cardiac function. In summary, resident macrophages orchestrate inflammatory responses improving cardiac remodelling, while recruited macrophages determine infarct size after I/R injury. These findings attribute distinct beneficial effects to different macrophage populations in the context of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Weinberger et al. (2023) studied Myocardial ischemia/reperfusion injury. Csf1rΔFIRE genetic deletion and PLX5622 CSF1R inhibition vs. Wildtype/control mice was evaluated on Cardiac remodeling (LVEF) and infarct size.
Synapse has enriched 10 related papers. Consider them for comparative context: